Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages

Podobne zapisy

• The Association of Notch2 and NF-κB Accelerates RANKL-Induced Osteoclastogenesis
  od: Fukushima, Hidefumi, i wsp.
  Wydane: (2008)
• Defective Osteoclastogenesis by IKKβ-null Precursors Is a Result of Receptor Activator of NF-κB Ligand (RANKL)-induced JNK-dependent Apoptosis and Impaired Differentiation
  od: Otero, Jesse E., i wsp.
  Wydane: (2008)
• Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
  od: Quan, Gui-Hua, i wsp.
  Wydane: (2015)
• IL-35 inhibits human osteoclastogenesis from monocytes induced by receptor-activator of NF-κB ligand
  od: Yago, Toru, i wsp.
  Wydane: (2018)
• PKA-induced Receptor Activator of NF-κB Ligand (RANKL) Expression in Vascular Cells Mediates Osteoclastogenesis but Not Matrix Calcification
  od: Tseng, Wendy, i wsp.
  Wydane: (2010)